Skip to content

A Comparative Study of Repeated Low-Level Red Light and Orthokeratology in Myopia Control in Children

A Comparative Study of Repeated Low-Level Red Light and Orthokeratology in Myopia Control in Children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127353
Enrollment
Unknown
Registered
2026-06-30
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children with myopia

Interventions

Repeated low-level red-light therapy group:None
OK group / Orthokeratology group:None

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Age 6–16 years; 2. Cycloplegic spherical equivalent refraction (SER) between -0.50 D and -6.00 D, inclusive; 3. Astigmatism <=2.50 D; 4. Anisometropia <=1.50 D; 5. Best-corrected visual acuity (BCVA) of logarithm of the minimum angle of resolution (LogMAR) 0.00 or better; 6. Completion of 3 years of follow-up; 7. No other myopia control treatment during follow-up, and no change in treatment modality or lens brand; 8. For the orthokeratology group, discontinuation of lens wear for no more than 1 week.

Exclusion criteria

Exclusion criteria: 1. Presence of systemic diseases or autoimmune diseases; 2. Strabismus, dry eye, ocular trauma, elevated intraocular pressure, keratoconus, or other ocular diseases except refractive error; 3. Previous history of ocular surgery; 4. Use of atropine, multifocal soft contact lenses, or defocus incorporated multiple segments lenses within 6 months before enrollment; 5. Poor compliance or inability to complete follow-up; 6. For the red-light therapy group, afterimage duration longer than 5 minutes; 7. Intolerance to the treatment.

Design outcomes

Primary

MeasureTime frame
Change in axial length from baseline;

Secondary

MeasureTime frame
Proportion of axial shortening;Treatment-related adverse events;Axial elongation rate;

Countries

China

Contacts

Public ContactNie Aiqin

Shenzhen People's Hospital

261376044@qq.com+86 755 25533018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026